"Kidney" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
| Descriptor ID |
D007668
|
| MeSH Number(s) |
A05.810.453
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Kidney".
Below are MeSH descriptors whose meaning is more specific than "Kidney".
This graph shows the total number of publications written about "Kidney" by people in this website by year, and whether "Kidney" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 7 | 8 | 15 |
| 1994 | 6 | 11 | 17 |
| 1995 | 14 | 13 | 27 |
| 1996 | 10 | 7 | 17 |
| 1997 | 13 | 10 | 23 |
| 1998 | 10 | 12 | 22 |
| 1999 | 11 | 7 | 18 |
| 2000 | 7 | 12 | 19 |
| 2001 | 6 | 16 | 22 |
| 2002 | 7 | 17 | 24 |
| 2003 | 9 | 21 | 30 |
| 2004 | 14 | 16 | 30 |
| 2005 | 11 | 17 | 28 |
| 2006 | 16 | 14 | 30 |
| 2007 | 14 | 11 | 25 |
| 2008 | 18 | 6 | 24 |
| 2009 | 15 | 18 | 33 |
| 2010 | 15 | 14 | 29 |
| 2011 | 17 | 10 | 27 |
| 2012 | 16 | 6 | 22 |
| 2013 | 21 | 11 | 32 |
| 2014 | 16 | 16 | 32 |
| 2015 | 21 | 9 | 30 |
| 2016 | 14 | 11 | 25 |
| 2017 | 20 | 6 | 26 |
| 2018 | 11 | 7 | 18 |
| 2019 | 16 | 7 | 23 |
| 2020 | 12 | 16 | 28 |
| 2021 | 5 | 20 | 25 |
| 2022 | 4 | 29 | 33 |
| 2023 | 1 | 16 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kidney" by people in Profiles.
-
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant. 2023 Aug 31; 38(9):2041-2051.
-
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study. Diabetes Obes Metab. 2023 10; 25(10):2989-2998.
-
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials. J Am Heart Assoc. 2023 07 04; 12(13):e028516.
-
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering. BMJ Open Diabetes Res Care. 2023 06; 11(3).
-
Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers. Clin J Am Soc Nephrol. 2023 08 01; 18(8):1059-1067.
-
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials. Kidney Int. 2023 Jul; 104(1):181-188.
-
Key questions regarding the SYMPLICITY HTN-3 trial - Authors' reply. Lancet. 2023 04 22; 401(10385):1337-1338.
-
Robot-assisted pyeloplasty for ureteropelvic junction obstruction in renal anomalies. J Pediatr Urol. 2023 08; 19(4):484.
-
Fluid Overload Precedes and Masks Cryptic Kidney Injury in Pediatric Acute Respiratory Distress Syndrome. Crit Care Med. 2023 06 01; 51(6):765-774.
-
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial. Am J Kidney Dis. 2023 Jul; 82(1):84-96.e1.